MAPK1 and malignant colon neoplasm: We have already demonstrated that β6-integrin is associated with chemo resistance in colon cancer, and β6-integrin could induce 5-FU resistance through the ERK/MAP kinase pathway and the β6-ERK2 direct binding[23].